Variable | TCM | ||||
---|---|---|---|---|---|
No (N = 804) | Yes (N = 804) | p-value | |||
n | % | n | % | ||
Gender | 0.99* | ||||
Female | 615 | 76.49 | 615 | 76.49 | |
Male | 189 | 23.51 | 189 | 23.51 | |
Age group, year | 0.99* | ||||
< 65 | 386 | 48.01 | 386 | 48.01 | |
≥ 65 | 418 | 51.99 | 418 | 51.99 | |
Mean (SD) | 64.57 (11.08) | 64.48 (11.08) | 0.8813a | ||
Urbanization level† | 0.0104* | ||||
1 (highest) | 207 | 25.75 | 240 | 29.85 | |
2 | 238 | 29.6 | 226 | 28.11 | |
3 | 106 | 13.18 | 134 | 16.67 | |
4 (lowest) | 253 | 31.47 | 204 | 25.37 | |
Baseline comorbidity | |||||
Alcohol-related disease | 4 | 0.5 | 1 | 0.12 | 0.3742b |
Cancer | 45 | 5.6 | 22 | 2.74 | 0.0041* |
Cardiovascular disease | 307 | 38.18 | 305 | 37.94 | 0.9182* |
Chronic kidney disease | 25 | 3.11 | 25 | 3.11 | 0.99* |
Chronic obstructive pulmonary disease | 188 | 23.38 | 241 | 29.98 | 0.0028* |
Diabetes mellitus | 212 | 26.37 | 185 | 23.01 | 0.1184* |
Dementia | 19 | 2.36 | 12 | 1.49 | 0.2043* |
Depression | 44 | 5.47 | 54 | 6.72 | 0.2972* |
Hyperlipidemia | 168 | 20.9 | 218 | 27.11 | 0.0035* |
Hypertension | 447 | 55.6 | 416 | 51.74 | 0.1211* |
Parkinson’s disease | 8 | 1 | 11 | 1.37 | 0.4887* |
Interval between diagnosis and initial TCM use, mean (days) | 611 | ||||
Follow-up time, mean (median; years) | 3.75 (2.86) | 5.38 (5.18) |